These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 3813593)

  • 1. Mast cell numbers in diffuse scleroderma.
    Nishioka K; Kobayashi Y; Katayama I; Takijiri C
    Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type I and II collagens and mast cells expression in the skin lesions from the patients with localized scleroderma].
    Wielowieyska-Szybińska D; Wojas-Pelc A; Dyduch G; Zawisz A
    Przegl Lek; 2008; 65(4):161-5. PubMed ID: 18724540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution of fibronectin in the skin of patients with scleroderma].
    Birembaut P; Cahuzac P; Delhomme H; Caron Y; Labat-Robert J; Robert L; Kalis B
    Ann Dermatol Venereol; 1982; 109(11):933-7. PubMed ID: 6762839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
    Ozbilgin MK; Inan S
    Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
    Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
    Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?
    Hawkins RA; Claman HN; Clark RA; Steigerwald JC
    Ann Intern Med; 1985 Feb; 102(2):182-6. PubMed ID: 3966756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular microfibrils are increased in localized and systemic scleroderma skin.
    Fleischmajer R; Jacobs L; Schwartz E; Sakai LY
    Lab Invest; 1991 Jun; 64(6):791-8. PubMed ID: 2046331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photofibrosis: a further histopathological change induced by PUVA therapy via the mast cell in guttate psoriasis. Preliminary report.
    Borroni G; Vignati G; Zaccone C; Gorani A; Brazzelli V; Rabbiosi G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():159-61. PubMed ID: 8073822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of mast cells and blood vessels in the skin of patients with cutaneous mucinosis.
    Martins C; Nascimento AP; Monte-Alto-Costa A; Alves Mde F; Carneiro SC; Porto LC
    Am J Dermatopathol; 2010 Jul; 32(5):453-8. PubMed ID: 20442641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells and fibrosis. The relevance to scleroderma.
    Claman HN
    Rheum Dis Clin North Am; 1990 Feb; 16(1):141-51. PubMed ID: 2406804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma].
    Gillery P; Maquart FX; Kalis B; Borel JP
    C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD1a and CD86 on scleroderma Langerhans cells.
    Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
    Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
    Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
    Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.
    Irani AM; Gruber BL; Kaufman LD; Kahaleh MB; Schwartz LB
    Arthritis Rheum; 1992 Aug; 35(8):933-9. PubMed ID: 1642658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
    Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
    J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of mast cells in non-neoplastic skin lesions.
    Naik R; Pai MR; Bantwal PB; Shankarnarayana ; Nayak KS; Gandhi A
    Indian J Pathol Microbiol; 2003 Apr; 46(2):173-5. PubMed ID: 15022902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and histochemical changes in the skin of patients with scleroderma.
    Ieremia G; Raica M; Cîmpean AM; Bocan V
    Rom J Morphol Embryol; 2007; 48(4):361-7. PubMed ID: 18060186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.